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Abstract
Background: Eating disorder (ED) patients often have comorbidities with other psychiatric disorders, especially with
mood disorders. Although recent studies suggest an intimate relationship between ED and bipolar disorder (BD),
the study on a broader bipolar spectrum definition has not been done in this population. We aimed to study the
occurrence of bipolar spectrum (BS) and comorbidities in eating disorder patients of a tertiary service provider.
Methods: Sixty-nine female patients diagnosed with anorexia nervosa, bulimia nervosa, or eating disorder not
otherwise specified were evaluated. The assessment comprised the Structured Clinical Interview for DSM-IV Axis I
Disorders (SCID-I), clinical criteria for diagnosis of the Zurich bipolar spectrum. Mann–Whitney tests compared
means of continuous variables. The association between categorical variables and the groups was described using
contingency tables and analyzed using the chi-square or Fisher's exact test. The level of significance alpha was set
at 5%.
Results: The results showed that 68.1% of patients had comorbidity with bipolar spectrum, and this was associated
with higher family income, proportion of married people, and comorbidity with substance use. The ED with BS
group showed higher rates of substance use comorbidity (40.4%) than the ED without BS group (13.6%).
Discussion: These results showed that the bipolar spectrum is a common comorbidity in patients with eating
disorders and is associated with correlates of clinical importance, notably the comorbidity with substance use. Due
to the pattern of similarity between the groups with and without comorbid bipolar spectrum in relation to various
outcomes evaluated, the identification of comorbidity can be difficult. However, the precise diagnosis and careful
identification of clinical correlates may contribute to future advances in treating these conditions. Further studies
are necessary to evaluate the association of other clinical correlates and its possible causal association.
Keywords: Bipolar disorder; Bipolar spectrum; Eating disorders; Comorbidity
Background
There is a growing body of evidence concerning bipolar
disorder (BD) comorbidity in patients with eating dis-
order (ED) (Blinder et al. 2006; McElroy et al. 2005).
Higher rates of BD compared to the general population
have been reported among ED patients (Hudson et al.
2007; McElroy et al. 2005) and have also been associated
with early onset, suicidal ideation, residual symptoms,
treatment resistance, and worsening course (Wildes
et al. 2007; McElroy et al. 2001; Fedorowicz et al. 2007;
Kaye et al. 2004).
The wide range in rates of BD comorbidity in patients
with ED is likely due to the use of different definitions of
bipolarity and the boundaries between ED and BD
(McElroy et al. 2005). Halmi et al. (1991) found higher
rates of atypical BD in female anorexia nervosa (AN) pa-
tients than in the control group (13.3% vs. 0%). Evaluat-
ing a community sample, Hudson et al. (2007) found the
occurrence of bipolar I (BP I) and II (BP II) disorders
ranging from 3% in AN to 17.7% in bulimia nervosa
(BN), including 12.5% in binge eating disorder (BED)
and 10.5% in subthreshold BED.
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Moreover, the prevalence of EDs not meeting the formal
criteria for AN or BN, such as ‘eating disorders not other-
wise specified’ (EDNOS) or subthreshold ED spectrum
disorders is considerably higher in BD patients (up to
3.6% to 10%) (McElroy et al. 2005). Evaluating 50 AN
patients regarding manic and depressive symptoms,
Wildes et al. (2007) found that 86% presented thresh-
old symptoms for depression and 60% for mania, and
it was associated with a history of self-induced vomit-
ing and suicidality.
Despite the recognized association between mood dis-
orders and ED, few studies described the relationship
with BD and its broader definition of bipolar spectrum
(BS). Most studies have been conducted using the DSM-
III-R criteria, and the estimates of prevalence of comor-
bid disorders in psychiatric settings may be skewed by
the imperfect recognition of BD (Mantere et al. 2004).
To our knowledge, the prevalence of soft forms of BD
(i.e., bipolar spectrum) in ED patients is not yet re-
ported. There is a need to analyze the prevalence and
correlates of BS in ED, first because BS may be under-
diagnosed due to phenomenology overlap and the sever-
ity of ED. Second, the axis I comorbidity pattern could
be clinically useful in helping recognize BS in this popula-
tion. Third, understanding this overlap raises the question
of shared vulnerability and, possible, physiopathology. The
aim of this study was to determine the prevalence of BS in
a well-defined sample of ED patients, evaluating the
prevalence of other axis I disorders.
Methods
The methods of ESPECTRA project are described in
greater details elsewhere (Campos et al. 2011). Women
aged 18 to 45 years were recruited from the Eating Dis-
order Unit (AMBULIM) of the Institute of Psychiatry of
the Clinical Hospital of the University of São Paulo,
School of Medicine. Considering that ED is much more
frequent in women than in men (Woodside et al. 2001),
we just enrolled females in order to exclude a possible
gender effect. Patients were included if they met the
DSM-IV-TR criteria for AN, BN, or EDNOS. BED patients
were excluded, and the absence of other comorbidities is
not an exclusion criterion (Campos et al. 2011).
The evaluation included completion of the Structured
Clinical Interview for DSM-IV Axis I Disorders (SCID-I)
(First et al. 1996) to establish the diagnosis of eating dis-
orders and comorbidities (psychotic disorders, mood
disorders, anxiety disorders, alcohol and substance use
disorders). Substances evaluated were amphetamine,
cannabis, cocaine, hallucinogen, opioids, and sedative/
hypnotic/anxiolytic. A clinical interview based on the
Zurich criteria identified the BS, and structured ques-
tionnaires determined demographic factors, illness in-
formation, and family history.
Details of the definition of BS are described elsewhere
(Angst et al. 2003). According to the redefinition of hypo-
mania based on the concept of overactivity, the Zurich cri-
teria consider a hypomanic episode duration of at least
1 day and no exclusion criteria, such as hypomania in-
duced by an antidepressant, substances (stimulants, al-
cohol, etc.), and other causes (corticosteroids, brain
lesion). Patients were divided into BS subtypes: BP I,
BP II, minor bipolar disorder (MinBP), and pure hypo-
mania (Pure Hyp).
A. Hypomanic syndrome
– Episode of at least two hypomanic symptoms
without consequences
– Euphoria, irritability, or overactivity
– Have personally experienced problems or
received comments from others that
something must be wrong with them
(consequences)
B. Hypomanic symptoms
– Present at least three out of seven signs and
symptoms of DSM-IV hypomania
The bipolar spectrum is defined as follows:
1. BD I: major depressive episodes associated with
mania
2. BD II: major depressive episodes associated with
(a) hypomanic syndrome or (b) hypomanic
symptoms
3. BD minor: dysthymia, minor depression, or recurrent
brief depression associated with (a) hypomanic
syndrome or (b) hypomanic symptoms
4. Pure hypomania: hypomanic syndrome (a) without
diagnosis of depression and (b) hypomanic
symptoms only
The protocol was approved by the local ethics com-
mittee, and it conformed to the 2008 Helsinki Declar-
ation (CAPPesq protocol number: 1154/09). Written
informed consent was obtained from all participants
prior to any study-related activities.
Data were analyzed using SPSS for Windows (version
14.0, SPSS, Chicago, IL, USA). Descriptive statistics in-
cluded means and standard deviations (SD) for con-
tinuous variables and percents for categorical variables.
Chi-square test and student's t test or Mann–Whitney
were used for group comparisons. All statistical tests
were two-tailed, and a significant level of 5% was con-
sidered for all tests.
Results
A total of 69 individuals with ED were evaluated. The
mean current age was 27.9 years (SD 6.4), most of the
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participants were not married (72.5%), and the mean off-
spring number was 0.46 (SD 0.98). Patients reported
13.3 years (SD 3.5) of education, 63.8% were not work-
ing, and 36.2% had no religion.
Most patients had comorbidity with BS (68.1%), and it
was associated with higher income (Table 1). Patients
with BS comorbidity were more likely to be married and
have more children than patients without BS. There was
no difference regarding mean age, level of education,
number of family members with other psychiatric disor-
ders, reported ethnicity, and religion.
High rates of comorbidities were found in both groups
of ED with and without BS, but there was no difference
in rates of any specific anxiety disorder (Table 2). The
ED with BS group showed higher rates of substance use
comorbidity (40.4%) than the ED without BS group
(13.6%) (OR = 4.298; P = 0.03).
Discussion
The present study shows a high prevalence (68.1%) of BS
in a well-defined population of 69 ED patients. This high
rate of BS is compatible with the findings of Alciati et al.
(2007) of 89% in 83 severely obese patients seeking surgi-
cal treatment. The definition of BS has been supported by
many studies showing that it is a highly prevalent condi-
tion with clinical implications, and there is a need to re-
define comorbidities according to this knowledge (Akiskal
et al. 2000). The Zurich definition of BS (Angst et al.
2003), epidemiology based, enriched the understanding of
soft bipolarity challenging the current DSM concepts. The
broader definitions result directly in strong increase of the
prevalence of BS. A reanalysis of the database of the Epi-
demiological Catchment Area (ECA) study indicated that
6.4% of the general population met the criteria for bipolar
spectrum (Judd and Akiskal 2003), while the original
study found 0.8% for BD. Data from the Sao Paulo Epi-
demiological Catchment Area study showed that the life-
time prevalence of BS was 8.3% (the softer forms of BD
representing 6.6%) and it was of great clinical importance
(Moreno and Andrade 2005; Moreno and Andrade 2010).
Merikangas et al. (2011) in a large study across 11 coun-
tries found that the overall prevalence of BS was 2.4%. In
addition to the findings mentioned above, we extended
previous investigations by demonstrating that ED is asso-
ciated with BS in its broader definition.
The BS is underdiagnosed in clinical practice (Angst
et al. 2003; Bschor et al. 2012), and comorbidity often is
an important factor that contributes to the delay in its
Table 1 Demographic and clinical features of ED patients with and without BS comorbidity
Variable ED without BS (N = 22) ED with BS (N = 47) P value
Mean (SD) CI (95%) Mean (SD) CI (95%)
Age (years) 27.59 (5.09) 25.34-29.85 27.98 (7.04) 25.91-30.05 0.995a
Offspring 0.09 (0.29) 0.00-0.22 0.64 (1.13) 0.31-0.97 0.030a
Level of education (years) 12.64 (4.17) 10.79-14.49 13.61 (3.13) 12.69-14.52 0.126a
Family income (R$)c 3,102.38 (4,196.26) 1,192.27-5,012.50 3,597.34-(2,497.63) 2,864.01-4,330.67 0.031a
First-degree relative with BD 0.05 (0.21) 0.00-0.14 0.11 (0.37) 0.00-0.22 0.547a
First-degree relative with depression 0.50 (0.74) 0.17-0.83 0.45 (0.54) 0.29-0.61 0.929a
First-degree relative with other mental disorders 0.09 (0.29) 0.00-0.22 0.21 (0.59) 0.04-0.39 0.481a
Relative with BD 0.09 (0.29) 0.00-0.22 0.13 (0.40) 0.01-0.24 0.825a
Relative with depression 0.91 (1.44) 0.27-1.55 1.17 (1.32) 0.78-1.56 0.171a
Relative with other mental disorders 0.32 (0.57) 0.07-0.57 0.38 (0.64) 0.19-0.57 0.712a
N % N %
Married No 20 90.9 30 63.8 0.019b
Yes 2 9.1 17 36.2
Ethnicity Caucasian 7 31.8 28 59.6 0.186b
Black 1 4.5 2 4.3
Asia 1 4.5 1 2.1
Other 13 59.1 16 34.0
Occupation Working 7 31.8 18 38.3 0.511b
Retired 3 13.6 7 14.9
Never worked 4 18.2 3 6.4
Unemployed 8 36.4 19 40.4
ED, eating disorder; BS, bipolar spectrum; CI, confidence interval. aMann-Whitney; bchi-square or Fisher's exact test; cBrazilian reais.
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identification. Patterns of psychiatric comorbidity sug-
gest one possible strategy for improving recognition of
bipolar disorder among patients presenting with depres-
sive symptoms, and these patients may benefit from add-
itional screening for bipolar disorder (Matza et al. 2005).
We compared the overall comorbidity profile of ED pa-
tients with or without bipolar spectrum to obtain a com-
prehensive view of the differences of current comorbidity
with ED. We found patterns of psychiatric comorbidity in
ED with and without BS to differ somewhat qualitatively.
This finding is in line with the results of previous studies
that indicate an association of ED with greater substance
use (Bulik et al. 2004).
Because of the severity of ED, comorbidities with other
axis I disorders may be neglected. It is important to note
that anxiety disorders and substance use are also highly
prevalent, representing conditions that should be sys-
tematically assessed. The understanding of how comor-
bidities can modify the course and outcome in this
population can be of clinical utility both in the diagnos-
tic and treatment field. Once these comorbidities be-
come more frequent than would be expected, it raises
the question about pathophysiological implications.
These findings must be considered in view of some
methodological limitations. First, historical illness vari-
ables were obtained retrospectively. Second, our group
of ED patients was selected in a tertiary and very special-
ized research center and may not be representative of
the community, and results may not be generalized. Our
study has several strengths such as the use of specific
and validated criteria for a broader definition of BD, and
structured interview and validated instruments for the
evaluation of axis I comorbidities.
Conclusions
This study supports previous data (McElroy et al. 2005;
Brietzke et al. 2011; Hudson et al. 2007) concerning the
relationship of ED and bipolar disorders, and shows the
importance of carefully evaluating ED patients. BS is
highly prevalent in women with ED and strongly associated
with substance use disorder comorbidity. A common liabil-
ity may underlie the expression of these disorders in a single
externalizing spectrum. One possibility is that this liability is
continuous and the risk of externalizing disorders is graded.
Another possibility is that the liability underlying the
externalization of spectrum disorders is categorical such that
individuals fall into groups of liability (Markon and Krueger
2005). A broader evaluation of psychiatric disorders beyond
the standardized categorization criteria can contribute to a
more realistic understanding of comorbidities.
A much more comprehensive assessment and meas-
urement of psychopathology can enhance operational
Table 2 Axis I comorbidities in ED with and without BS
ED without BS (N = 22) ED with BS (N = 47) P
value
OR CI (95%)
N % N % Lower limit Upper limit
Major depressive disorder 20 90.9 21 44.7 0.000 0.164 0.043 0.631
Dysthymic disorder 1 4.5 - 0.0 0.319 0.955 0.871 1.046
Bipolar I disorder - 0.0 18 38.3 0.000 1.621 1.294 2.030
Bipolar II disorder - 0.0 6 12.8 0.090 1.146 1.028 1.279
Cyclothymic disorder - 0.0 - 0.0 NAa
Alcohol abuse 2 9.1 5 10.6 1.000 1.190 0.212 6.676
Alcohol dependence 3 13.6 8 17.0 1.000 1.299 0.309 5.460
Alcohol useb 5 22.7 13 27.7 0.774 1.300 0.398 4.249
Substance abuse - 0.0 2 4.3 0.461 1.044 0.983 1.109
Substance dependence 3 13.6 17 36.2 0.086 3.589 0.926 13.917
Substance usec 3 13.6 19 40.4 0.03 4.298 1.114 16.575
Alcohol/substance used 7 31.8 22 46.8 0.300 1.886 0.650 5.467
Panic disorder 8 36.4 19 40.4 0.797 1.187 0.417 3.380
Agoraphobia without panic disorder 2 9.1 2 4.3 0.587 0.444 0.058 3.382
Social phobia 11 50.0 16 34.0 0.290 0.516 0.184 1.447
Specific phobia 4 18.2 10 21.3 1.000 1.216 0.335 4.414
Obsessive-compulsive disorder 5 22.7 12 25.5 1.000 1.166 0.353 3.845
Post-traumatic stress disorder 2 9.1 4 8.5 1.000 0.930 0.157 5.507
Generalized anxiety disorder - 0.0 3 6.4 0.546 1.068 0.991 1.151
Fisher's exact test was used. ED, eating disorder; BS, bipolar spectrum; OR, odds ratio. aOR not applicable due to the existence of cells with zero frequency;
bcombination of alcohol abuse and dependence; ccombination of drug abuse and dependence; dalcohol/substance use.
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diagnoses and lead clinicians to broader examinations
(Angst 2007), and lifetime substance use is a correlate
that can be of great importance in differentiating disor-
ders that have common characteristics. This kind of in-
formation can build a body of evidence supporting a
dimensional approach in diagnosing these conditions,
and as long as new studies incorporate this wider ap-
proach, the results will be directly seen in the number of
patients diagnosed.
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